Quality of life in chronic conditions using patient-reported measures and biomarkers: a DEA analysis in type 1 diabetes

Table 6 Scales, risk factors and efficiencies, overall and by diabetes duration group

	All		0–12 years		13–23 years		24–36 years		37–75 years
	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Scales
GenW	61	23	60	23	62	23	61	24	60	22
MoE	66	22	64	23	65	22	66	22	68	22
FreW	56	21	53	22	56	21	57	21	60	21
ManD	65	19	63	18	64	20	64	19	68	17
DiEx	57	23	57	24	56	24	57	24	60	22
NLD	77	22	77	21	77	22	78	22	77	22
NLBS	71	27	72	27	69	28	70	26	71	26
SuDC	81	19	81	19	81	19	81	18	79	19
AcDC	70	20	69	21	70	19	70	20	69	20
CoDC	80	23	79	24	78	23	82	23	79	23
MDMT	78	20	76	21	77	21	79	19	79	19
Risk factors
HbA1c	60.9	11.9	58.9	13.0	62.0	12.4	61.7	11.0	61.0	10.7	¤
SBP	127.4	14.3	124.0	12.6	124.9	14.3	128.1	13.9	132.3	14.6	¤
LDL	2.44	0.76	2.56	0.79	2.46	0.69	2.42	0.74	2.34	0.81	¤
Efficiency
Intermediate	0.68	0.17	0.67	0.18	0.67	0.18	0.68	0.17	0.71	0.16
Capability	0.92	0.06	0.92	0.06	0.92	0.06	0.92	0.06	0.91	0.06
GenW share (%)	10.7	10.7	10.3	10.5	11.6	12.6	10.9	10.7	9.8	9.0
MoE share (%)	15.9	23.2	13.9	22.0	15.7	23.3	16.3	23.5	17.8	23.9
HbA1c’ share	26.9	22.5	30.6	23.9	24.3	20.9	25.1	21.9	27.2	22.7
SBP’ share	20.7	18.4	23.9	18.5	23.8	18.7	19.7	18.5	15.6	16.4	¤
LDL’ share	25.8	22.4	21.2	20.4	24.5	22.1	28.0	23.3	29.6	22.8	¤
n	1456		353		365		352		376

* = differences between genders (p < 0.001). ¤ = difference between duration groups (p < 0.001). SD Standard deviation

ISSN: 2191-1991